Afamin is a promising novel marker for metabolic syndrome and related diseases

References

• Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 375(9710), 181–183 (2010).
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009).
   Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3), 356–359 (2002).
   Google Scholar
• Church TS, Thomas DM, Tudor-Locke C et al. Trends over 5 decades in US occupation-related physical activity and their associations with obesity. PLoS ONE 6(5), e19657 (2011).
   Google Scholar
• Pereira MA, Kartashov AI, Ebbeling CB et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 365(9453), 36–42 (2005).
   Google Scholar
• Palaniappan L, Carnethon MR, Wang Y et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27(3), 788–793 (2004).
   Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25), 3143–3421 (2002).
   Google Scholar
• Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339(4), 229–234 (1998).
   Google Scholar
• Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28(7), 1769–1778 (2005).
   Google Scholar
• Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119(10), 812–819 (2006).
   Google Scholar
• Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49(4), 403–414 (2007).
   Google Scholar
• Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56(4), 1010–1013 (2007).
   Google Scholar
• Kronenberg F, Kollerits B, Kiechl S et al. Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ. Cardiovasc. Genet. 7(6), 822–829 (2014).
   Google Scholar
• Lichenstein HS, Lyons DE, Wurfel MM et al. Afamin is a new member of the albumin, a-fetoprotein, and vitamin D-binding protein gene family. J. Biol. Chem. 269, 18149–18154 (1994).
   Google Scholar
• Nishio H, Dugaiczyk A. Complete structure of the human alpha-albumin gene, a new member of the serum albumin multigene family. Proc. Natl Acad. Sci. USA 93, 7557–7561 (1996).
   Google Scholar
• Nishio H, Heiskanen M, Palotie A, Belanger L, Dugaiczyk A. Tandem arrangement of the human serum albumin multigene family in the sub-centromeric region of 4q: evolution and chromosomal direction of transcription. J. Mol. Biol. 259(1), 113–119 (1996).
   Google Scholar
• Voegele AF, Jerkovic L, Wellenzohn B et al. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry 41(49), 14532–14538 (2002).
   Google Scholar
• Heiser M, Hutter-Paier B, Jerkovic L et al. Vitamin E binding protein afamin protects neuronal cells in vitro. J. Neural. Transm. Suppl. (62), 337–345 (2002).
   Google Scholar
• Kratzer I, Bernhart E, Wintersperger A et al. Afamin is synthesized by cerebrovascular endothelial cells and mediates 21 alpha-tocopherol transport across an in vitro model of the blood–brain barrier. J. Neurochem. 108(3), 707–718 (2009).
   Google Scholar
• Jerkovic L, Voegele AF, Chwatal S et al. Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J. Proteome Res. 4(3), 889–899 (2005).
   Google Scholar
• Dieplinger B, Egger M, Gabriel C et al. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin. Chim. Acta 425, 236–241 (2013).
   Google Scholar
• Koninger A, Edimiris P, Koch L et al. Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome. Endocr. Connect. 3(3), 120–126 (2014).
   Google Scholar
• Seeber B, Morandell E, Lunger F, Wildt L, Dieplinger H. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod. Biol. Endocrinol. 12(1), 88 (2014).
   Google Scholar
• Hubalek M, Buchner H, Mortl MG et al. The vitamin E-binding protein afamin increases in maternal serum during pregnancy. Clin. Chim. Acta 434, 41–47 (2014).
   Google Scholar
• Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 175(2), 189–202 (2004).
   Google Scholar
• Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp. Gerontol. 44(3), 136–160 (2009).
   Google Scholar